glutathione pathway to triple negative cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Metabolic interplay between exogenous cystine
Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



